Let’s Take a BiTE Out of CRS and Neurotoxicity
Immunotherapy has made tremendous progress as cancer-directed therapy has evolved, particularly in the field of T cell-engaging therapies. Common and serious side effects of these types of therapies include Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS). Join us as Bejal Kikani, MSN, FNP-BC, WHNP-BC, discusses the recognition, grading, and treatment of these toxicities.
Category
  • Advanced Practice Provider
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 NCPD/CNE
  • 1.00 Participation
Peritoneal Carcinomatosis: The Good, the Bad, and the Ugly
Jeremiah 'Jig' Deneve, DO, FACS, provides an overview of the natural history, treatment, and outcome for peritoneal carcinomatosis.
Category
  • Advanced Practice Provider
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 NCPD/CNE
  • 1.00 Participation
CAR-T 101: Overview of CAR-T Therapy and Management of Toxicities
Megan McElfresh, PA-C, will review chimeric antigen receptor therapy, associated side effects, and the treatment or prevention of side effects.
Category
  • Advanced Practice Provider
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 NCPD/CNE
  • 1.00 Participation
Lung Cancer Screening Essentials
This multidisciplinary Panel Presentation will describe the importance of CT-based lung cancer screening, indications and criteria for screening, the optimal structure and requirements of a screening program, and the current state of screening at UNC. We will present practical information relevant to providers who may order screening CT and/or may discuss screening with patients.
Category
  • Advanced Practice Provider
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 NCPD/CNE
  • 1.00 Participation
Oncologic Emergencies: Superior Vena Cava Syndrome, Hypercalcemia, and SIADH
Allison Phillips, MPAP, MHPE, PA-C, reviews the clinical manifestations, underlying causes, and management of some of the most common emergencies facing patients undergoing cancer treatment, including Superior Vena Cava Syndrome, Hypercalcemia, and SIADH.
Category
  • Advanced Practice Provider
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 NCPD/CNE
  • 1.00 Participation
Integrating Germline Pharmacogenomic Testing into Oncology Care
Patients undergoing treatment for cancer utilize many medications that have relevant drug-gene interactions. The use of pharmacogenomic testing can assist with drug selection, drug dosing, and the development of personalized medication monitoring plans. Amber Cipriani, PharmD, BCOP, will describe some common examples of drug-gene interactions relevant to oncology. She will also discuss current efforts to expand the use of pharmacogenomic testing into current clinical practice.
Category
  • Advanced Practice Provider
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 NCPD/CNE
  • 1.00 Participation
Physical Therapy Approaches to Oncology Care: Beyond Lymphedema
Tailored for medical providers, this session led by a physical therapist addresses challenges like speech and swallowing difficulties or pelvic floor issues in gynecological cancer. Explore the pivotal role of physical therapy in survivorship care plans and delve into current research supporting interventions for head and neck, gynecological, breast cancer, and other oncological conditions. Emphasizing interdisciplinary collaboration, we'll discuss the synergy between medical providers and physical therapists in delivering optimal cancer care. Additionally, learn the art of patient education in oncology rehabilitation, empowering medical providers to effectively communicate the role of physical therapy in cancer care.
Category
  • Advanced Practice Provider
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 NCPD/CNE
  • 1.00 Participation